Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03881345

Ongoing Registry of Treatment of Venous Thromboembolism

Ongoing registration of patients with venous thromboembolism treated by means of antithrombotic therapy, thrombolisys, open surgery, endovenous desobstruction and stenting.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Deep Vein Thrombosis Cardiovascular Diseases Embolism Embolism and Thrombosis Lung Diseases Postthrombotic Syndrome Pulmonary Embolism Respiratory Tract Diseases Thromboses, Venous Thrombosis Thrombosis Embolism Vascular Diseases Venous Insufficiency Venous Thrombosis

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Pirogov Russian National Research Medical University

Moscow, 190000, Russia

Location status: Recruiting

Location contact

Yury Stoyko, MD, PhD

CONTACT

About this study

Data of patients with VTE treated in different Russian medical centers are entered in a prospective digital database, and continuously updated.

There is planned to conduct prospective randomized, cohort and observational studies on the site of register

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • case of venous thrombosis of a limb or pulmonary embolus

Exclusion criteria

  • no exclusion criteria

Treatment and study plan

Anticoagulants

Drug

anticoagulation according to the main diagnosis

Open Surgery

Procedure

removal of blood clots with open surgery

Thrombolysis

Procedure

removal of blood clots with thrombolysis

Venous stenting

Procedure

elimination of vein obstruction by stenting

Primary outcomes

  1. Veins patency

    Time frame: Baseline, 3 and 12 months post-intervention

    Change in patency target veins assessed by duplex ultrasonography in different follow up periods due to different treatment methods

Secondary outcomes

  1. Postthrombotic syndrome

    Time frame: Baseline, 3 and 12 months post-intervention

    the presence and severity of postthrombotic syndrome on the Villalta scale

  2. QoL SF-36

    Time frame: Baseline, 3 and 12 months post-intervention

    Change in Quality of Life (QoL), assessed by "Short form 36" health survey (SF-36). Total scale range: from 0 to 800. SF-36 consists of 8 subscales. Each subscale range: 0 - 100. Subscales are combined using a special algorithm described in the instructions for the SF-36. For total scale the higher value represent the worse QoL.

  3. QoL AVVQ

    Time frame: Baseline, 3 and 12 months post-intervention

    Change in Quality of Life (QoL), assessed by "Aberdeen Varicose Vein Questionnaire" (AVVQ). The AVVQ is a disease-specific QoL questionnaire aimed at venous disease. Total scale range: from 0 to 100, where the higher score represent worse QoL.

Study contacts

Contact information is provided by the study sponsor or research team.

Evgeny Ilyukhin

CONTACT

[email protected]

+79218451722

Sponsors and collaborators

Lead sponsor

Medalp Private Surgery Clinic

Other

Collaborators

  • State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia

Registry information

Official study title

Russian Registry of Treatment of Venous Thromboembolism

Acronym: RRT VTE

Important dates

Study start
2019
Primary completion
2036
Study completion
2036
First posted
Mar 19, 2019
Registry last updated
May 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.